{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T04:05:30Z","timestamp":1787889930588,"version":"build-2784847793"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jocn-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.jocn.2022.09.005","type":"journal-article","created":{"date-parts":[[2022,9,13]],"date-time":"2022-09-13T07:29:59Z","timestamp":1663054199000},"page":"66-72","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Clopidogrel hyper-response increases peripheral hemorrhagic complications without increasing intracranial complications in endovascular aneurysm treatments requiring dual antiplatelet therapy"],"prefix":"10.1016","volume":"105","author":[{"given":"Christopher C.","family":"Young","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David I.","family":"Bass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Carroll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin N.","family":"Vanent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chungeun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajeev D.","family":"Sen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah H.","family":"Feroze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denzel","family":"McCray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cory M.","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Barber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis J.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"Levitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jocn.2022.09.005_b0005","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1161\/STROKEAHA.116.015308","article-title":"Use of platelet function testing before pipeline embolization device placement: a multicenter cohort study","volume":"48","author":"Adeeb","year":"2017","journal-title":"Stroke"},{"key":"10.1016\/j.jocn.2022.09.005_b0010","doi-asserted-by":"crossref","first-page":"721","DOI":"10.3174\/ajnr.A3418","article-title":"Clopidogrel hyper-response and bleeding risk in neurointerventional procedures","volume":"34","author":"Goh","year":"2013","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.jocn.2022.09.005_b0015","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1136\/neurintsurg-2013-010976","article-title":"Variability in initial response to standard clopidogrel therapy, delayed conversion to clopidogrel hyper-response, and associated thromboembolic and hemorrhagic complications in patients undergoing endovascular treatment of unruptured cerebral aneurysms","volume":"6","author":"Delgado Almandoz","year":"2014","journal-title":"J Neurointerv Surg"},{"key":"10.1016\/j.jocn.2022.09.005_b0020","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3174\/ajnr.A3621","article-title":"Last-recorded P2Y12 reaction units value is strongly associated with thromboembolic and hemorrhagic complications occurring up to 6 months after treatment in patients with cerebral aneurysms treated with the pipeline embolization device","volume":"35","author":"Delgado Almandoz","year":"2014","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.jocn.2022.09.005_b0025","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1136\/neurintsurg-2015-011844","article-title":"Platelet reactivity and hemorrhage risk in neurointerventional procedures under dual antiplatelet therapy","volume":"8","author":"Nishi","year":"2016","journal-title":"J NeuroInterv Surg"},{"key":"10.1016\/j.jocn.2022.09.005_b0030","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1056\/NEJMoa1907096","article-title":"A genotype-guided strategy for oral P2Y12 inhibitors in primary PCI","volume":"381","author":"Claassens","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jocn.2022.09.005_b0035","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1056\/NEJMoa0809171","article-title":"Cytochrome P-450 polymorphisms and response to clopidogrel","volume":"360","author":"Mega","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jocn.2022.09.005_b0040","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2174\/1574884712666170227154654","article-title":"Potential usefulness of clopidogrel pharmacogenetics in cerebral endovascular procedures and carotid artery stenting","volume":"12","author":"Duconge","year":"2017","journal-title":"Curr Clin Pharmacol"},{"key":"10.1016\/j.jocn.2022.09.005_b0045","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.wneu.2012.02.040","article-title":"The pharmacogenomics of clopidogrel","volume":"77","author":"Levitt","year":"2012","journal-title":"World Neurosurg"},{"key":"10.1016\/j.jocn.2022.09.005_b0050","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s40262-014-0230-6","article-title":"Clinical pharmacokinetics and pharmacodynamics of clopidogrel","volume":"54","author":"Jiang","year":"2015","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.jocn.2022.09.005_b0055","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.ahj.2012.12.024","article-title":"Thienopyridine efficacy and cigarette smoking status","volume":"165","author":"Bliden","year":"2013","journal-title":"Am Heart J"},{"key":"10.1016\/j.jocn.2022.09.005_b0060","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/neuros\/nyy395","article-title":"Precision of VerifyNow P2Y12 assessment of clopidogrel response in patients undergoing cerebral aneurysm flow diversion","volume":"85","author":"Bender","year":"2019","journal-title":"Neurosurgery"},{"key":"10.1016\/j.jocn.2022.09.005_b0065","doi-asserted-by":"crossref","first-page":"890","DOI":"10.3171\/2017.5.JNS162307","article-title":"Management of antiplatelet therapy in patients undergoing neuroendovascular procedures","volume":"129","author":"Kim","year":"2018","journal-title":"J Neurosurg"},{"key":"10.1016\/j.jocn.2022.09.005_b0070","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1136\/neurintsurg-2019-015288","article-title":"Dose adjustment of clopidogrel in hyper-responder patients with unruptured intracranial aneurysms treated with stents","volume":"12","author":"Gonz\u00e1lez","year":"2020","journal-title":"J NeuroInterv Surg"},{"key":"10.1016\/j.jocn.2022.09.005_b0075","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1136\/neurintsurg-2019-015091","article-title":"Prospective study on embolization of intracranial aneurysms with the pipeline device: the PREMIER study 1 year results","volume":"12","author":"Hanel","year":"2019","journal-title":"J NeuroInterv Surg"},{"key":"10.1016\/j.jocn.2022.09.005_b0080","doi-asserted-by":"crossref","DOI":"10.1136\/neurintsurg-2012-010582","article-title":"Pre-procedure P2Y12 reaction units value predicts perioperative thromboembolic and hemorrhagic complications in patients with cerebral aneurysms treated with the Pipeline Embolization Device","author":"Delgado Almandoz","year":"2013","journal-title":"J Neurointerv Surg"},{"key":"10.1016\/j.jocn.2022.09.005_b0085","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1227\/NEU.0000000000000978","article-title":"P2Y12 reaction units: effect on hemorrhagic and thromboembolic complications in patients with cerebral aneurysms treated with the pipeline embolization device","volume":"78","author":"Daou","year":"2016","journal-title":"Neurosurgery"},{"key":"10.1016\/j.jocn.2022.09.005_b0090","doi-asserted-by":"crossref","first-page":"e674","DOI":"10.1016\/j.wneu.2020.03.046","article-title":"Platelet function testing with a VerifyNow-directed personalized antiplatelet strategy and associated rates of thromboembolic complications after pipeline embolization for complex cerebral aneurysms","volume":"138","author":"Neyens","year":"2020","journal-title":"World Neurosurg"},{"key":"10.1016\/j.jocn.2022.09.005_b0095","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1136\/neurintsurg-2014-011145","article-title":"Effect of antiplatelet therapy and platelet function testing on hemorrhagic and thrombotic complications in patients with cerebral aneurysms treated with the pipeline embolization device: a review and meta-analysis","volume":"8","author":"Skukalek","year":"2016","journal-title":"J Neurointerv Surg"},{"key":"10.1016\/j.jocn.2022.09.005_b0100","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1477-9560-7-4","article-title":"Comparison of VerifyNow-P2Y12 test and Flow Cytometry for monitoring individual platelet response to clopidogrel. What is the cut-off value for identifying patients who are low responders to clopidogrel therapy?","volume":"7","author":"Godino","year":"2009","journal-title":"Thromb J"},{"key":"10.1016\/j.jocn.2022.09.005_b0105","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J Royal Statis Soc Series B"},{"key":"10.1016\/j.jocn.2022.09.005_b0110","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1136\/neurintsurg-2019-014765","article-title":"Predictive value of platelet reactivity unit (PRU) value for thrombotic and hemorrhagic events during flow diversion procedures: a meta-analysis","volume":"11","author":"Ajadi","year":"2019","journal-title":"J Neurointerv Surg"},{"key":"10.1016\/j.jocn.2022.09.005_b0115","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1136\/neurintsurg-2020-015893","article-title":"Incorporation of transradial approach in neuroendovascular procedures: defining benchmarks for rates of complications and conversion to femoral access","volume":"12","author":"Almallouhi","year":"2020","journal-title":"J Neurointerv Surg"},{"key":"10.1016\/j.jocn.2022.09.005_b0120","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1136\/neurintsurg-2020-015992","article-title":"Lower complication rates associated with transradial versus transfemoral flow diverting stent placement","volume":"13","author":"Li","year":"2021","journal-title":"J Neurointerv Surg"},{"key":"10.1016\/j.jocn.2022.09.005_b0125","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.wneu.2016.04.002","article-title":"Thromboelastography parameter predicts outcome after subarachnoid hemorrhage: an exploratory analysis","volume":"96","author":"Ramchand","year":"2016","journal-title":"World Neurosurg"},{"key":"10.1016\/j.jocn.2022.09.005_b0130","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1177\/0271678X20921974","article-title":"Microvascular platelet aggregation and thrombosis after subarachnoid hemorrhage: a review and synthesis","volume":"40","author":"Clarke","year":"2020","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.jocn.2022.09.005_b0135","unstructured":"Li W, Zhu W, Wang A, et al: Effect of adjusted antiplatelet therapy on preventing ischemic events after stenting for intracranial aneurysms. Stroke 2021;Sep 20;STROKEAHA120032989."},{"key":"10.1016\/j.jocn.2022.09.005_b0140","unstructured":"Bass DI, Young CC, Park MS, et al. Severe, intolerable fatigue associated with hyper-response to clopidogrel. World Neurosurg 2021; Sep 24;S1878-8750(21)01418-2."}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586822003587?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586822003587?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T21:31:03Z","timestamp":1760823063000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0967586822003587"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":28,"alternative-id":["S0967586822003587"],"URL":"https:\/\/doi.org\/10.1016\/j.jocn.2022.09.005","relation":{},"ISSN":["0967-5868"],"issn-type":[{"value":"0967-5868","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clopidogrel hyper-response increases peripheral hemorrhagic complications without increasing intracranial complications in endovascular aneurysm treatments requiring dual antiplatelet therapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocn.2022.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}